These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8817442)

  • 21. Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats.
    Schmitt F; Remy S; Dariel A; Flageul M; Pichard V; Boni S; Usal C; Myara A; Laplanche S; Anegon I; Labrune P; Podevin G; Ferry N; Nguyen TH
    Gastroenterology; 2010 Sep; 139(3):999-1007, 1007.e1-2. PubMed ID: 20546738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human UDP-glucuronosyl transferases: chemical defence, jaundice and gene therapy.
    Brierley CH; Burchell B
    Bioessays; 1993 Nov; 15(11):749-54. PubMed ID: 8292005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I.
    Bočkor L; Bortolussi G; Iaconcig A; Chiaruttini G; Tiribelli C; Giacca M; Benvenuti F; Zentilin L; Muro AF
    Gene Ther; 2017 Oct; 24(10):649-660. PubMed ID: 28805798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
    Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
    Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.
    Fox IJ; Chowdhury JR; Kaufman SS; Goertzen TC; Chowdhury NR; Warkentin PI; Dorko K; Sauter BV; Strom SC
    N Engl J Med; 1998 May; 338(20):1422-6. PubMed ID: 9580649
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1.
    Apgar JF; Tang JP; Singh P; Balasubramanian N; Burke J; Hodges MR; Lasaro MA; Lin L; Millard BL; Moore K; Jun LS; Sobolov S; Wilkins AK; Gao X
    CPT Pharmacometrics Syst Pharmacol; 2018 Jun; 7(6):404-412. PubMed ID: 29637732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II].
    Drenth JP; Peters WH; Jansen JB
    Ned Tijdschr Geneeskd; 2002 Aug; 146(32):1488-90. PubMed ID: 12198827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats.
    Seppen J; van Til NP; van der Rijt R; Hiralall JK; Kunne C; Elferink RP
    Gene Ther; 2006 Apr; 13(8):672-7. PubMed ID: 16267566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of Hyperbilirubinemia in Gunn Rats after Transplantation of Human Induced Pluripotent Stem Cell-Derived Hepatocytes.
    Chen Y; Li Y; Wang X; Zhang W; Sauer V; Chang CJ; Han B; Tchaikovskaya T; Avsar Y; Tafaleng E; Madhusudana Girija S; Tar K; Polgar Z; Strom S; Bouhassira EE; Guha C; Fox IJ; Roy-Chowdhury J; Roy-Chowdhury N
    Stem Cell Reports; 2015 Jul; 5(1):22-30. PubMed ID: 26074313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic conversion of bilirubin monoglucuronide to diglucuronide in uridine diphosphate-glucuronyl transferase-deficient man and rat by bilirubin glucuronoside glucuronosyltransferase.
    Chowdhury JR; Jansen PL; Fischberg EB; Daniller A; Arias IM
    J Clin Invest; 1978 Jul; 62(1):191-6. PubMed ID: 96142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.
    Seppen J; Bosma PJ; Goldhoorn BG; Bakker CT; Chowdhury JR; Chowdhury NR; Jansen PL; Oude Elferink RP
    J Clin Invest; 1994 Dec; 94(6):2385-91. PubMed ID: 7989595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.
    Maruo Y; Behnam M; Ikushiro S; Nakahara S; Nouri N; Salehi M
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):523-6. PubMed ID: 26697581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats.
    Jia Z; Dankó I
    Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new type of defect in the gene for bilirubin uridine 5'-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I.
    Aono S; Yamada Y; Keino H; Sasaoka Y; Nakagawa T; Onishi S; Mimura S; Koiwai O; Sato H
    Pediatr Res; 1994 Jun; 35(6):629-32. PubMed ID: 7936809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer.
    Nguyen TH; Aubert D; Bellodi-Privato M; Flageul M; Pichard V; Jaidane-Abdelghani Z; Myara A; Ferry N
    Gene Ther; 2007 Sep; 14(17):1270-7. PubMed ID: 17611583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation of Gunn rats with autologous fibroblasts expressing bilirubin UDP-glucuronosyltransferase: correction of genetic deficiency and tumor formation.
    Seppen J; Tada K; Ottenhoff R; Sengupta K; Chowdhury NR; Chowdhury JR; Bosma PJ; Oude Elferink RP
    Hum Gene Ther; 1997 Jan; 8(1):27-36. PubMed ID: 8989992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man.
    Findlay KA; Kaptein E; Visser TJ; Burchell B
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2879-83. PubMed ID: 10946897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three Japanese patients with Crigler-Najjar syndrome type I carry an identical nonsense mutation in the gene for UDP-glucuronosyltransferase.
    Koiwai O; Yasui Y; Hasada K; Aono S; Sato H; Fujikake M; Aoki T
    Jpn J Hum Genet; 1995 Sep; 40(3):253-7. PubMed ID: 8527799
    [No Abstract]   [Full Text] [Related]  

  • 39. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1.
    King CD; Green MD; Rios GR; Coffman BL; Owens IS; Bishop WP; Tephly TR
    Arch Biochem Biophys; 1996 Aug; 332(1):92-100. PubMed ID: 8806713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
    Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ
    J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.